Q1 2025 Holdings
Filed 2025-05-15 | 28 holdings | $2.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvalent Inc(NUVL) | COM | 670703107 | $373.7M | 5,269,433 | 17.1% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $294.7M | 4,492,032 | 13.5% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $218.5M | 6,178,111 | 10.0% |
| Beigene LTD(ONC) | SPONSORED ADS | 07725L102 | $181.3M | 666,024 | 8.3% |
| Merus N V | COM | N5749R100 | $141.8M | 3,369,699 | 6.5% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $134.1M | 2,610,197 | 6.1% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $96.7M | 4,394,556 | 4.4% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $89.9M | 3,329,909 | 4.1% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $65.3M | 1,946,168 | 3.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $64.1M | 1,696,481 | 2.9% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $60.1M | 1,210,971 | 2.8% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $53.7M | 8,963,655 | 2.5% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $38.9M | 1,511,932 | 1.8% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $35.9M | 961,707 | 1.6% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $35.3M | 59,679 | 1.6% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $34.5M | 858,664 | 1.6% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $34.4M | 451,359 | 1.6% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $34.3M | 2,127,205 | 1.6% |
| Metsera Inc | COM | 59267L107 | $32.4M | 1,191,462 | 1.5% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $28.2M | 2,095,079 | 1.3% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $25.3M | 6,741,172 | 1.2% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $24.5M | 627,423 | 1.1% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $22.9M | 1,465,334 | 1.0% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $18.8M | 4,236,346 | 0.9% |
| Erasca Inc(ERAS) | COM | 29479A108 | $14.8M | 10,802,354 | 0.7% |
| Edgewise Therapeutics Inc(EWTX)Call | COM | 28036F105 | $11.0M | 500,000 | 0.5% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $9.6M | 1,314,018 | 0.4% |
| Immatics N.v(IMTX) | SHS | N44445109 | $8.6M | 1,907,108 | 0.4% |